ProPharma Group News and Blog

Your source for content carefully curated for life science consulting, medical information, pharmacovigilance, and regulatory affairs professionals. ProPharma Group’s subject matter experts regularly share their expertise in the form of blogs, feedback regarding recent guidance and regulations, case studies, industry trends, and more.
Search or filter posts by category
Phase Appropriate Controls and GMPs in Cell and Gene Therapy
January 15, 2020 Compliance expert Benjamin Frey discusses the development of quality systems and controls for investigational cell and gene therapies.

Read More
How to Safely Launch Medical Cannabis Products in Germany
January 2, 2020 Our expert's advice on how to navigate through the main challenges confronting you when distributing and marketing medical cannabis in the German market.

Read More
Five Steps Toward a Mature Data Integrity Culture
December 11, 2019 How can your company demonstrate the trustworthiness of GxP data as expected by regulators? Learn more about establishing a culture of quality in your organization.

Read More
The Right Time for Portugal-Born Pharma Projects to Step-Up to...
November 27, 2019 The Portuguese pharma industry has developed into a market of national and international products using local manufacturing. Learn how outsourcing to service providers can support continued growth.

Read More
Analytical Methods for the Investigation of Carcinogenic Nitrosamines in APIs...
November 25, 2019 Learn more about the analytical methods which can be utilised for the testing of APIs and finished drug formulations for the presence of nitrosamines.

Read More
Three Steps Towards Fulfilling the EMA Nitrosamine Advice
November 11, 2019 How a results-driven, chemistry-based strategy will enable companies to meet MAH responsibilities with the EMA.

Read More
Contact Us